Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06034327 · ClinicalTrials.gov registry record · NA
Efficacy in Controlling Myopia in Young Children Using a Novel Spectacle Lens
A NA study of Myopia and Juvenile Myopia, sponsored by SightGlass Vision.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 14
- Study locations
NCT06034327 is a NA study of Myopia and Juvenile Myopia that is actively recruiting participants, run by SightGlass Vision. The registered enrollment target is 150 participants, below the 266-participant average among 90 other Myopia trials with a reported enrollment target (44% lower). The trial reports 14 study locations across 9 states.
The verdict
NCT06034327, a NA study of Myopia and Juvenile Myopia, is actively recruiting participants, sponsored by SightGlass Vision.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 14
- Study locations
Study Summary
This is a conventional efficacy trial to validate the results from previous clinical trials for younger children; the 12-month efficacy results will be used to predict the 3-year treatment efficacy. This is a randomized, controlled (1:1), multisite, subject- and observer-masked, 2-arm parallel group study.
Conditions Studied
Interventions
- DEVICE Single vision, impact-resistant spectacle lenses; Test Arm
- DEVICE Single vision, impact-resistant spectacle lenses; Control Arm
Study Locations (14)
California
- Elsa Pao, OD - Oakland
- Scripps Poway Eyecare - San Diego
- Pacific Rims Optometry - San Francisco
- Paje Optometric - Santa Ana
Ohio
- Athens Eye Care - Athens
- Procare Vision Centers, Inc. - Granville
Texas
- Texas State Optical - Dowlen - Beaumont
- Bellaire Family Eye Care - Bellaire
Florida
- Omega Vision Center - Longwood
Georgia
- Marietta Eye Clinic - Marietta
Illinois
- Ilinois College of Optometry - Chicago
Kansas
- Kannarr Eye Care - Pittsburg
Massachusetts
- New England College of Optometry - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2023-09-18 |
| Est. Completion | 2027-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06034327
The ClinicalTrials.gov registry entry for NCT06034327 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 266-participant average among 90 other Myopia trials with a reported enrollment target (44% lower). The listed sponsor is SightGlass Vision, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which Single vision, impact-resistant spectacle lenses; Test Arm is the first listed.
NCT06034327 reports 14 study locations spanning 9 distinct geographic areas - top geographies include California, Ohio, Texas.
Frequently Asked Questions
What is clinical trial NCT06034327 about?
NCT06034327 is a clinical study titled "Efficacy in Controlling Myopia in Young Children Using a Novel Spectacle Lens". This is a conventional efficacy trial to validate the results from previous clinical trials for younger children; the 12-month efficacy results will be used to predict the 3-year treatment efficacy. This is a randomized, controlled (1:1), multisite, subject- and observer-masked, 2-arm parallel grou...
What is the current status of trial NCT06034327?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2023-09-18. Estimated completion is 2027-03-31.
What conditions does trial NCT06034327 study?
This clinical trial studies the following conditions: Myopia, Juvenile Myopia, Myopia Progression.
What interventions are being tested in trial NCT06034327?
The interventions under investigation include: Single vision, impact-resistant spectacle lenses; Test Arm (DEVICE), Single vision, impact-resistant spectacle lenses; Control Arm (DEVICE).
Who is sponsoring clinical trial NCT06034327?
This trial is sponsored by SightGlass Vision, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06034327 being conducted?
This trial has 14 study locations across California, Florida, Georgia, Illinois, Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Efficacy of Repeated Low-level Red-light Therapy in Myopia Control
RECRUITING · NA
-
Comprehensive Assessment of Multiple Products (CAMP)
RECRUITING · NA
-
Children's Viewing Behavior
RECRUITING · NA
-
Violet Light for the Suppression of Myopia
RECRUITING · NA
-
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
RECRUITING · NA
-
Wavelength Intervention for Nearsighted Kids
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.